Noven Announces Webcast of 2007 Annual Meeting of Stockholders

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that it plans to webcast its 2007 Annual Stockholders’ Meeting, scheduled for May 18, 2007, at 10:00 a.m. Eastern Time, at Noven’s facilities in Miami, Florida. The live webcast will be available via the Internet at, and thereafter a rebroadcast will be accessible at the same site for at least two weeks.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot® (the most prescribed estrogen patch in the U.S.) and Daytrana™ (the first and only patch approved for the treatment of ADHD). Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See for additional information.

Alina Bowman
Investor Relations Coordinator